GlassScriptPhysician profile
Keith C Raziano
NPI 1194781070
$980.69
in general payments reported to CMS, 2019-2025
26 companies · $156 in 2025
The $156 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.14 · 2020: $251 · 2021: $199 · 2022: $64.88 · 2023: $141 · 2024: $72.23 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330 · Education: $39.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.76 |
| Education | $39.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $162.27 | 2021-2025 | Proclaim, Octrode |
| Medtronic, INC. | $97.98 | 2021-2025 | Intellis Adaptivestim |
| Medtronic USA, INC. | $95.32 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $79.44 | 2020 | |
| Arbor Pharmaceuticals, INC. | $75.02 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $55.32 | 2019-2025 | Iovera, Zilretta |
| Tenex Health INC. | $46.55 | 2020 | |
| Azurity Pharmaceuticals, INC. | $36.62 | 2024 | Horizant |
| Vertex Pharmaceuticals Incorporated | $26.64 | 2025 | |
| Electronic Waveform Lab, INC. | $25.26 | 2019-2020 | |
| Abbvie INC. | $24.88 | 2025 | |
| Trice Medical, INC. | $23.43 | 2023 | |
| Nalu Medical, INC. | $22.72 | 2021 | |
| Masimo Corporation | $22.66 | 2023 | Patient Safetynet System |
| Spr Therapeutics, INC | $20.06 | 2025 | Sprint Pns System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $18.80 | 2025 | Triluron, Hymovis |
| Relievant Medsystems, INC. | $18.38 | 2023 | Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.85 | 2019 | |
| Grt US Holding, INC. | $16.36 | 2021 | |
| International Rehabilitative Sciences, INC | $15.84 | 2023 | Rs 4i Plus Sequential Stimulator |
| Forte Bio-Pharma LLC | $14.85 | 2021 | |
| Pfizer INC. | $14.69 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $14.65 | 2021 | |
| Redhill Biopharma INC. | $13.33 | 2021 | |
| Biodelivery Sciences International, INC. | $11.72 | 2021 | |
| Merit Medical Systems INC | $10.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Raziano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.